Richard Benton Phillips

Richard Benton Phillips

General Counsel at Chugai Biopharmaceuticals, Inc.

70 year
Health Technology
Consumer Services
Distribution Services

Profile

Richard Benton Phillips is currently the Vice President of Regulatory Affairs at Chugai Biopharmaceuticals, Inc. He previously held positions at various pharmaceutical companies including Amgen, Johnson & Johnson, Pfizer Inc., Sandoz, Inc., Cougar Biotechnology, Inc., SGX Pharmaceuticals, Inc., Chugai Pharma USA LLC, Janssen Oncology, Inc., G.D.
Searle LLC, and Puma Biotechnology, Inc. He has also earned a doctorate degree from the University of California, Berkeley in 1982 and an undergraduate degree from the University of California, Irvine in 1976.

Richard Benton Phillips active positions

CompaniesPositionStart
General Counsel 2011-05-16
All active positions of Richard Benton Phillips

Former positions of Richard Benton Phillips

CompaniesPositionEnd
PUMA BIOTECHNOLOGY, INC. General Counsel 2014-11-06
Corporate Officer/Principal 2010-02-28
General Counsel 2009-07-12
AMGEN INC. General Counsel -
General Counsel 2003-12-31
See the detail of Richard Benton Phillips's experience

Training of Richard Benton Phillips

University of California, Irvine Undergraduate Degree
University of California, Berkeley Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Benton Phillips's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
AMGEN INC.

Health Technology

JOHNSON & JOHNSON

Health Technology

PFIZER, INC.

Health Technology

PUMA BIOTECHNOLOGY, INC.

Health Technology

Private companies7

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

G.D. Searle LLC

See company connections
  1. Stock Market
  2. Insiders
  3. Richard Benton Phillips
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW